Skip to main content

Table 2 Baseline demographics, duration of disease and therapy

From: Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker

  UC N = 41 Non UC N = 30
Age (years)
 Mean (SD) 39.3 (18.8) 28.9 (11.0)
 Range 24–60 21–62
Gender, male, n (%) 21 (50) 7 (25)
Duration of UC (years)
 Mean (SD) 11.42 (9.43)  
 Range 1–37  
Treatment (current)
 TNFα-blocker 21  
 Glucocorticoids 11  
 Mesalazine 24  
 Immuno-suppressive 7  
 No 4